Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- PMID: 30350310
- DOI: 10.1002/ijc.31937
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
Abstract
Estimates of the worldwide incidence and mortality from 36 cancers and for all cancers combined for the year 2018 are now available in the GLOBOCAN 2018 database, compiled and disseminated by the International Agency for Research on Cancer (IARC). This paper reviews the sources and methods used in compiling the cancer statistics in 185 countries. The validity of the national estimates depends upon the representativeness of the source information, and to take into account possible sources of bias, uncertainty intervals are now provided for the estimated sex- and site-specific all-ages number of new cancer cases and cancer deaths. We briefly describe the key results globally and by world region. There were an estimated 18.1 million (95% UI: 17.5-18.7 million) new cases of cancer (17 million excluding non-melanoma skin cancer) and 9.6 million (95% UI: 9.3-9.8 million) deaths from cancer (9.5 million excluding non-melanoma skin cancer) worldwide in 2018.
Keywords: GLOBOCAN; cancer; global estimates; incidence; mortality.
© 2018 UICC.
Similar articles
-
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12. CA Cancer J Clin. 2018. PMID: 30207593
-
Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.Int J Cancer. 2015 Mar 1;136(5):E359-86. doi: 10.1002/ijc.29210. Epub 2014 Oct 9. Int J Cancer. 2015. PMID: 25220842
-
Cancer statistics for the year 2020: An overview.Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588. Online ahead of print. Int J Cancer. 2021. PMID: 33818764
-
Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021.Lancet Infect Dis. 2024 Sep;24(9):974-1002. doi: 10.1016/S1473-3099(24)00176-2. Epub 2024 Apr 15. Lancet Infect Dis. 2024. PMID: 38636536 Free PMC article.
-
Cancer incidence and mortality patterns in Europe: Estimates for 40 countries and 25 major cancers in 2018.Eur J Cancer. 2018 Nov;103:356-387. doi: 10.1016/j.ejca.2018.07.005. Epub 2018 Aug 9. Eur J Cancer. 2018. PMID: 30100160 Review.
Cited by
-
Poria cocos inhibits the invasion, migration, and epithelial-mesenchymal transition of gastric cancer cells by inducing ferroptosis in cells.Eur J Med Res. 2024 Nov 5;29(1):531. doi: 10.1186/s40001-024-02110-0. Eur J Med Res. 2024. PMID: 39497198 Free PMC article.
-
Effect of Chinese Herbal Medicine Therapy on Overall and Cancer Related Mortality in Patients With Advanced Nasopharyngeal Carcinoma in Taiwan.Front Pharmacol. 2021 Jan 29;11:607413. doi: 10.3389/fphar.2020.607413. eCollection 2020. Front Pharmacol. 2021. PMID: 33708119 Free PMC article.
-
Tumor buster - where will the CAR-T cell therapy 'missile' go?Mol Cancer. 2022 Oct 19;21(1):201. doi: 10.1186/s12943-022-01669-8. Mol Cancer. 2022. PMID: 36261831 Free PMC article. Review.
-
Urinary exosomal microRNA-96-5p and microRNA-183-5p expression as potential biomarkers of bladder cancer.Mol Biol Rep. 2021 May;48(5):4361-4371. doi: 10.1007/s11033-021-06451-5. Epub 2021 Jun 4. Mol Biol Rep. 2021. PMID: 34085193
-
Artificial Intelligence in Dermatology Image Analysis: Current Developments and Future Trends.J Clin Med. 2022 Nov 18;11(22):6826. doi: 10.3390/jcm11226826. J Clin Med. 2022. PMID: 36431301 Free PMC article. Review.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical